Trends in net survival for 1,834,894 patients with cancer from 16 population-based cancer registries in Japan, 2000-14 (CONCORD-3) - PubMed
5 hours ago
- #CONCORD-3
- #cancer survival
- #population-based registry
- Study analyzed net survival trends for 1,834,894 cancer patients in Japan from 2000-2014 using data from 16 population-based cancer registries (CONCORD-3).
- Five-year net survival improved for several cancers, including brain tumors (27.9%-46.3%), ovarian cancer (35.5%-46.3%), and stomach cancer (50.5%-60.3%).
- Survival remained high or improved for breast cancer (85.9%-93.0%), childhood lymphoma, and prostate cancer.
- Survival for melanoma remained unchanged, while pancreatic cancer had persistently low survival (6.9%-8.3%).
- Japan showed higher survival rates for esophageal (36.0%), liver (30.1%), and lung cancers (32.9%) compared to other countries.
- Survival for melanoma, hematologic malignancies, and childhood cancers was lower in Japan than in Western countries.
- The study highlights the need for international collaboration to improve cancer control strategies.